Isofluran Baxter

Isoflurane, the active ingredient in Isofluran Baxter, is an inhalational anesthetic presented as a solution for inhalation use. It is used to induce and maintain general anesthesia in surgical patients.

GNH USA supplies Isofluran Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Isoflurane is an inhalational anesthetic used in the management of the central nervous system to achieve controlled loss of consciousness during surgery.

- Induction of general anesthesia: provides rapid onset of unconsciousness for surgical procedures. - Maintenance of general anesthesia: sustains adequate depth of anesthesia throughout operations. - Pediatric anesthesia: enables safe and controlled anesthesia in children undergoing surgery.

Isoflurane may cause a range of adverse reactions during and after administration.

Common Side Effects: - Cough or airway irritation - Nausea and vomiting - Hypotension - Tachycardia - Dizziness - Dry mouth

Serious or Rare Side Effects: - Malignant hyperthermia - Hepatic toxicity - Renal impairment - Severe arrhythmias - Seizures - Anaphylactic reactions

When using Isoflurane, careful patient assessment and monitoring are essential.

- Cardiovascular monitoring: observe blood pressure and heart rate for hypotension or tachycardia. - Respiratory assessment: ensure airway patency and adequate ventilation. - Malignant hyperthermia susceptibility: avoid in patients with known susceptibility. - Hepatic function: use cautiously in severe liver disease. - Drug interactions: review concomitant medications that may potentiate respiratory depression. - Store at ambient temperature: keep container sealed, protect from light and moisture.

Isoflurane can interact with other agents that affect the central nervous system or respiratory function.

Major Interactions (Avoid): - Potent CYP2E1 inhibitors (e.g., disulfiram) may increase plasma concentrations. - Concurrent use of other inhalational anesthetics can cause additive depressant effects. - Opioids or sedatives may lead to profound respiratory depression.

Moderate Interactions (Monitor Closely): - Benzodiazepines and other CNS depressants. - Monoamine oxidase inhibitors (MAOIs). - Anticholinergic agents. - Beta‑blockers affecting heart rate control. - Nitrous oxide when used in combination.